Citations

Clear

3042 citation(s) found for "Kumar, S".

Apolipoprotein A-I Infusions in Coronary Artery Disease: A Systematic Review
Ahmad, Rimsha , Hussain, Syed Sadam, Niaz, Mahnoor, Frishman, William H. , Aronow, Wilbert S., Khan, Saifullah , Kumar, Mahesh , Aronow, Wilbert S.

Mayo Clinic

Cardiology in Review | July 17, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/crd.0000000000001002 | PMID 40673933 Get It

Coronary artery disease (CAD) is the leading cause of death globally. Apolipoprotein A-1 (apoA-1), the primary protein component of high-density lipoprotein (HDL), facilitates reverse cholesterol transport and has emerged as a potential therapeutic target. While pharmacologic efforts to raise HDL-C levels have failed to reduce cardiovascular events, focus has shifted to HDL functionality, particularly cholesterol efflux capacity (CEC). ApoA-1 infusions have demonstrated antiatherogenic effects in preclinical models and early human trials by enhancing CEC and promoting cholesterol clearance. This review summarizes the rationale and evolving clinical trial landscape investigating apoA-1 infusions as a novel therapy for CAD prevention and treatment.
Development of the TrendBurden Survey: Assessing Perceived Documentation Burden among Health Professionals in the United States
Sloss, Elizabeth A. , Owoyemi, Ayomide , Sidwell, Kathleen, Abdul, Shanawaz, Dawood, Gigi, Allen, Matthew R., Austria, Davis , Chekeni, Faraaz, Corley, Sarah , Grigg, A O, Hartman, Vince , Levy, Deborah R , Marshall, Kyle , Murphy, Judy, Newman, Barry, Phillips, Toni, Smith, Kevin D., Szymanski, James , Mishra, Anup Kumar , Abdul, Shanawaz, Pope, Zachary, Chekeni, Faraaz , Grigg, Aaron, Johnson, Kevin B. , Marshall, Kyle, Murphy, Judy, Rossetti, Sarah Collins

Mayo Clinic

Applied Clinical Informatics | July 17, 2025 | Volume: 16 | Issue: 03 | Pages: 662-675

10.1055/a-2562-0910 | PMID 40669861 Get It

AbstractDocumentation burden contributes to health professional burnout and negatively impacts health professional well-being and patient care quality. Yet, there is a gap in the literature regarding an effective measure to assess the perceived documentation burden of health professionals in a wide range of care settings over time.We developed and administered a pulse survey to trend, with subsequent administrations, the perceived documentation burden of health professionals in all care settings in the United States over time.A multimethods approach was used which included conducting a scoping review of the literature to identify and then curate a set of potential survey items based on scoping review results. Next, a modified Delphi approach was used with clinical informatics experts for consensus-driven item selection and pulse survey development. Finally, we administered the pulse survey nationally using snowball sampling through professional listservs and networks of organizations.The scoping review helped to identify constructs and items to include on the pulse survey. After four iterations of the modified Delphi approach, consensus was reached on five final items for the pulse survey, labeled “TrendBurden.” The first administration of “TrendBurden” was completed by 1,253 healthcare professionals in April 2024. Most respondents (73.26%) disagreed that the time and effort spent documenting patient care is appropriate, with 77.42% reporting finishing work later or needing to work from home due to excessive documentation tasks. Seventy-four point three-eight percent agreed that the effort or time required to complete documentation tasks impedes patient care, and less than one-third (31.76%) agreed that the EHR is easy to use.The “TrendBurden” Pulse Survey was developed through a scoping review of the literature and expert consensus. The resulting five-question pulse survey was administered nationally and provided insight into current perceptions of documentation burden among healthcare professionals.
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification Products
Dingli, Sarah , Rothweiler, Paul , Binder, Moritz , Cook, Joselle , Gertz, Morie A. , Hayman, Suzanne R. , Kapoor, Prashant , Kourelis, Taxiarchis , Kumar, Shaji , Warsame, Rahma , Lin, Yi , Erdman, Arthur G. , Dingli, David , Kumar, Shaji K , Warsame, Rahma , Dingli, David , Gertz, Morie A , Binder, Moritz , Cook, Joselle M , Siddiqui, Mustaqeem

Mayo Clinic

American Journal of Hematology | July 15, 2025 | Volume: 100 | Issue: 9 | Pages: 1705-1708

10.1002/ajh.70001 | PMID 40662471 Get It

Clinical Validation of a Computed Tomography Image-Based Machine Learning Model for Segmentation and Quantification of Shoulder Muscles
Rajabzadeh-Oghaz, Hamidreza , Elwell, Josie , Aibinder, William R. , Gobbato, Bruno , Wessell, Daniel E. , Kumar, Vikas , Roche, Christopher , Roche, Christopher P , Aibinder, William R , Schoch, Bradley S.

Mayo Clinic

Algorithms | July 15, 2025 | Volume: 18 | Issue: 7 | Pages: 432

10.3390/a18070432 Get It

Introduction: We developed a computed tomography (CT)-based tool designed for automated segmentation of deltoid muscles, enabling quantification of radiomic features and muscle fatty infiltration. Prior to use in a clinical setting, this machine learning (ML)-based segmentation algorithm requires rigorous validation. The aim of this study is to conduct shoulder expert validation of a novel deltoid ML auto-segmentation and quantification tool. Materials and Methods: A SwinUnetR-based ML model trained on labeled CT scans is validated by three expert shoulder surgeons for 32 unique patients. The validation evaluates the quality of the auto-segmented deltoid images. Specifically, each of the three surgeons reviewed the auto-segmented masks relative to CT images, rated masks for clinical acceptance, and performed a correction on the ML-generated deltoid mask if the ML mask did not completely contain the full deltoid muscle, or if the ML mask included any tissue other than the deltoid. Non-inferiority of the ML model was assessed by comparing ML-generated to surgeon-corrected deltoid masks versus the inter-surgeon variation in metrics, such as volume and fatty infiltration. Results: The results of our expert shoulder surgeon validation demonstrates that 97% of ML-generated deltoid masks were clinically acceptable. Only two of the ML-generated deltoid masks required major corrections and only one was deemed clinically unacceptable. These corrections had little impact on the deltoid measurements, as the median error in the volume and fatty infiltration measurements was <1% between the ML-generated deltoid masks and the surgeon-corrected deltoid masks. The non-inferiority analysis demonstrates no significant difference between the ML-generated to surgeon-corrected masks relative to inter-surgeon variations. Conclusions: Shoulder expert validation of this CT image analysis tool demonstrates clinically acceptable performance for deltoid auto-segmentation, with no significant differences observed between deltoid image-based measurements derived from the ML generated masks and those corrected by surgeons. These findings suggest that this CT image analysis tool has potential to reliably quantify deltoid muscle size, shape, and quality. Incorporating these CT image-based measurements into the pre-operative planning process may facilitate more personalized treatment decision making, and help orthopedic surgeons make more evidence-based clinical decisions.
Space Oncology: A Comprehensive Scoping Review
Niknam, Nafise , Akbarialiabad, Hossein , Kouhanjani, Mohsen Farjoud , Varghese, Lydia Johnson Kolaparambil , González, Amy Berrington de , Melin, M. Mark , Shafie’ei, Mohammad , Mousavi, Seyedeh Maryam , Hosseini, Seyed Ali , Taha, Seyed Reza , Grada, Ayman , Akbari, Zahra , Jokar-Derisi, Armita , Jurga, Marta , Das, Saswati , D’Urbano, Jessica , Hakim, Gabriella, Sadeghian, Najmeh , Tarbox, Michelle , West, Cameron , Hosseini, Seyed Hossein , Squire, Timothy , Christiansen, Rowena , Melin, Matthew M , Farjoud Kouhanjani, Mohsen , Kolaparambil Varghese, Lydia Johnson , Russomano, Thais , Murrell, D F , Leachman, Sancy A , Akbari, Zahra , Derisi, Armita Jokar , Das, Saswati , D'Urbano, Jessica , Hakim, Gabriella , Sadeghian, Najmeh , Paydar, Shahram , Tarbox, Michelle , West, Cameron , Ghorashi, Seyyed Mojtaba , Hosseini, Seyed Hossein , Squire, Timothy , Christiansen, Rowena , Berrington de Gonzalez, Amy , Leachman, Sancy A. , Kumar, Ajay , Bunick, Christopher G.

Mayo Clinic

Wilderness & Environmental Medicine | July 14, 2025 | Volume: 36 | Issue: 1_suppl | Pages: No page available

10.1177/10806032251349442 | PMID 40653854 Get It

Space exploration exposes astronauts to unique conditions such as microgravity and space radiation, potentially influencing gene expression and triggering carcinogenesis. Paradoxically, these extreme environments could uncover other pro-treatment aspects of cancer biology. Despite numerous reviews addressing these aspects in isolation, a comprehensive synthesis of the effects of space stressors on cancer development is incomplete. This scoping review aims to provide a holistic perspective on the influence of spaceflight and associated stressors—including gravitation (hyper- and microgravity), radiation, and vibration—on the potential for cancer development and altered cellular mechanisms. We adhered to the PRISMA-ScR checklist for our review. A multitiered search strategy was employed in English, starting with a preliminary keyword identification in Google Scholar and PubMed. Subsequently, the main search was conducted across five databases—Cochrane, Embase, PubMed, Scopus, and Web of Science—until 22 February 2024. All included studies were thoroughly assessed by two independent reviewers. Of the 15,553 identified articles, 158 were deemed eligible. The majority (92%) were experimental studies, predominantly cell-based (74.17%). Breast (15.19%), thyroid (13.92%), and hematopoietic (11.40%) cancers were the most frequently examined. Spaceflight stressors could affect different biological systems variably, with microgravity impacting spatial growth and metastasis, and cosmic radiation exerting both tumor-suppressive and mutagenic effects. Our findings highlight the need for large-scale, prolonged analog studies mimicking space conditions to enhance mission safety and shed light on the nuanced effects of space stressors on cancer. Additionally, further extensive studies need to be performed in the true weightlessness of spaceflight, both animal-based and on human tissue (cell cultures and potentially whole perfusion organ models), in addition to crew pre/intra/post-flight long-duration evaluations. Furthermore, this unique research avenue may reveal cancer cell sensitivities to these stressors, opening new pathways for innovative therapeutic strategies in cancer treatment.
The Angiography Pattern of Buerger’s Disease: Challenges and Recommendations
Fazeli, Bahare , Poredoš, Pavel , Stephen, Edwin , Bashar, Abul Hasan Muhammad , Kozak, Matija, Catalano, M. , Salman, Mussaad Mohammaed Al, Altarazi, Louay, Dimakakos, Evangelos , Erer, Dilek , Farkas, Katalin , Fokou, Marcus , Ionac, Mihai , Iwai, Takehisa , Karahan, Oğuz , Kashani, Daniel , Kota, Albert Abhinay , Kröger, Knut , Kubat, Emre , Premkumar, Prabhu , Marcoccia, Antonella , Pandey, Sandeep Raj , Patel, Malay , Pécsvárady, Zsolt, Polat, Adıl , Ravari, Hassan , Selvaraj, Dheepak, Sharebiani, Hiva , Stanek, Agata , Taha, Wassila , Taheri, Hossein , Yuwono, Hendro Sudjono , Zor, Mustafa Hakan , Stephen, Edwin , Bashar, Abul Hasan Muhammad , Catalano, Mariella , Dimakakos, Evangelos , Farkas, Katalin , Ionac, Mihai , Karahan, Oguz , Kashani, Daniel , Kota, Albert , Kubat, Emre , Kumar, Prabhu Prem , Marcoccia, Antonella , Polat, Adil , Ravari, Hassan , Sharebiani, Hiva , Stanek, Agata , Liew, Aaron , Antignani, Pier Luigi , Desai, Sanjay, Hüssein, Emad , Małecki, Rafał , Schernthaner, G. , Szuba, Andrzej

Mayo Clinic

Journal of Clinical Medicine | July 8, 2025 | Volume: 14 | Issue: 14 | Pages: 4841

10.3390/jcm14144841 | PMID 40725544 Get It

In 2023, the VAS international working group on Buerger’s Disease (BD) recommended two diagnostic criteria based on a prior Delphi study: “definitive” and “suspected”. The “definitive” criteria are history of smoking, typical angiography, and typical histopathological features. All three features are mandatory to confirm a “definitive” diagnosis of BD. The conundrum is—what features should be considered typical of BD angiography? According to this review, segmental occlusion of infrapopliteal arteries, corkscrew collaterals that appear to continue the occluded arterial segment (Martorell’s sign) or bypass the segmental occlusion, absence of atherosclerotic plaque or aneurysm could differentiate BD from ASO. Hence, for “typical” BD angiography, these manifestations should certainly be considered. However, data for differentiating angiography patterns of BD from the small- and medium-sized vasculitis including Behcet’s disease, scleroderma, hepatitis associated vasculitis, and anti-phospholipid syndrome are limited. Further studies for investigating the angiography pattern in BD patients in early and late presentation of BD, particularly in the patients with long-term follow up, are highly recommended.
Lumbar Endplate Hounsfield Units Enhance Transforaminal Lumbar Interbody Fusion Subsidence Prediction Compared to Trabecular Hounsfield Units Alone
Levy, Hannah A. , Magera, Christopher A., Messer, Caden, Potes, Maria Astudillo , Allen, Tyler, Hamouda, Abdelrahman M. , Bydon, Mohamad , Fogelson, Jeremy L. , Elder, Benjamin D. , Currier, Bradford L. , Freedman, Brett A. , Sebastian, Arjun S. , Messer, Caden J., Astudillo Potes, Maria D, Hamouda, Abdelrahman , Bydon, Mohamad , Freedman, Brett A , Kumar, Jayanth, Nassr, Ahmad , Karamian, Brian A.

Mayo Clinic

Global Spine Journal | July 4, 2025 | Volume: 16 | Issue: 1 | Pages: 639-649

10.1177/21925682251356986 | PMID 40613106 Get It

Study Design Retrospective cohort analysis. Objective (1) Develop a novel computed tomography (CT)-based assessment of endplate bone density (EP-HU), (2) Determine if EP-HU was a stronger predictor than trabecular HU for subsidence after transforaminal lumbar interbody fusion (TLIF). Methods All adult patients who underwent single-level TLIF for lumbar degenerative conditions at an academic center between 2017-2022 were retrospectively identified. EP-HU was calculated from a 2 mm superior and inferior endplate region on the preoperative mid sagittal CT scans, accounting for surface undulations. Lumbar vertebral HUs (trabecular region) were determined in a standard fashion on axial CT. EP-HU + vertebral HU served as an aggregate bone quality metric. Interbody subsidence (≥2 mm threshold) was directly measured on the endplate-facing surface of 1 year CT scans. Univariate and multivariate analysis compared subsidence based on CT bone metrics. Results A total of 114 patients met the inclusion/exclusion criteria. There was no significant difference in fusion or reoperation rate based on subsidence occurrence. Both vertebral HU ( P = .012) and EP-HU ( P < .001) were associated with subsidence. In receiver operating curves, EP-HU was more optimal for subsidence prediction than vertebral HU, but the aggregate metric further optimized the specificity and total area under the curve. In a predictive logistic regression model EP-HU + vertebral HU (aggregate HU < 515 odds ratio: 7.82, P < .001) was a strong independent predictor of subsidence. Conclusion Preoperative calculation of EP-HUs in addition to vertebral HUs may enhance prediction of TLIF subsidence where aggregate endplate and vertebral HU < 515 can be used to identify high risk patients.
Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System
Aperna, Fnu, Abdelmagid, Maymona, Kumar, Mahesh, Butterfield, Joseph H. , Pongdee, Thanai , Yi, Cecilia Y. Arana , Patnaik, Mrinal M. , Arber, Daniel A. , Orazi, Attilio , Chen, Dong , Reichard, Kaaren K. , Gangat, Naseema , Pardanani, Animesh , Tefferi, Ayalew , Abdelmagid, Maymona G, Arana Yi, Cecilia Y , Patnaik, Mrinal , Chen, Dong , Arber, Daniel A , Orazi, Attilio , Yi, Cecilia Arana

Mayo Clinic

American Journal of Hematology | July 3, 2025 | Volume: 100 | Issue: 9 | Pages: 1566-1576

10.1002/ajh.27764 | PMID 40607735 Get It

ABSTRACTThe current study includes 910 patients with systemic mastocytosis (SM) seen at the Mayo Clinic from 1968 to 2024. The primary objective was to examine the prognostic contribution of the International Consensus Classification (ICC), in the context of the Mayo Alliance Prognostic System (MAPS) for SM. World Health Organization classification (WHO‐HAEM5) subcategories included (i) indolent/smoldering SM (ISM/SSM; N = 518), (ii) SM associated with another hematological neoplasm (SM‐AHN; N = 273), with the latter including both myeloid and lymphoid neoplasms, (iii) aggressive SM (ASM; N = 106), and (iv) WHO‐defined mast cell leukemia (MCL; N = 13), which included mast cells with both “mature” and “immature” morphology. The ICC‐defined subcategories were mostly similar with the exception that SM‐AHN was replaced by SM associated with another myeloid neoplasm (SM‐AMN; N = 235) and WHO‐defined MCL was replaced by ICC‐defined MCL (N = 8), which included only those with immature MC morphology. Overall survival (OS) was similar between WHO‐defined MCL (median 1.8 years) vs. SM‐AHN (median 2.3 years; p = 0.3) but significantly different between ICC‐defined MCL (median 0.08 years) vs. SM‐AMN (median 2.0 years; p < 0.01). Significant difference in OS was also apparent between ICC‐defined SM‐AMN and SM associated with lymphoid neoplasm (SM‐ALN; median 8.1 years; HR 3.4; p < 0.01). Multivariable analysis confirmed the inter‐independent prognostic contributions of both ICC‐defined morphologic subcategories and MAPS risk variables, including age > 60 years, anemia, alkaline phosphatase > ULN, and platelet count < 150 × 109/L (p < 0.03 in all instances); the same was not true for WHO‐HAEM5‐defined SM subcategories. The addition of mutational information into the multivariable model resulted in ousting anemia and inclusion of ASXL1 (p < 0.01), SRSF2 (p = 0.01), and NRAS (p = 0.01) mutations as additional risk factors. Classification of SM by ICC is prognostically more accurate, compared to WHO‐HAEM5, and strengthens the prognostic contribution of morphology to current clinical and molecular risk models.
The Role Of Senolytics In Reducing Senescence Induced By Cannabinoids And Nicotine In Prenatal Human Lung
Alam, Imad El, Belgacemi, Randa , Zana-Taeib, Elodie, Danopoulos, Soula , Alam, Denise Al , Glass, Ian A. , Zana‐Taïeb, Elodie , Boyer, Laurent , Rehan, Virender Kumar , Prakash, Y. S. , Pabelick, Christina M.

Mayo Clinic

Physiology | July 1, 2025 | Volume: 40 | Issue: S1 | Pages: No page available

10.1152/physiol.2025.40.s1.1566 Get It

Tandem exposure to cannabinoids and nicotine during pregnancy poses significant risks to fetal development and health including low birth weight, preterm birth, and perinatal death. However, the effect of co-exposure with the most prominent cannabinoids found in Cannabis sativa (Trans-Δ-9- tetrahydrocannabinol (THC) and cannabidiol (CBD)) alongside nicotine on fetal lung development is not well understood. This study aims to investigate the combinatorial impact of CBD, THC, and nicotine, on human lung development through investigating cellular senescence and the potential role of senolytics in alleviating these effects. Human fetal lung explants from 10 to 16 weeks gestation were cultured on air-liquid interface and treated with various concentrations of nicotine (1µM), CBD, and THC (5µM, or 2.5µM each when used in combination), for 72 hours. To assess the effect of senolytics, the explants were also treated for 48 hours with a combination of CBD, THC, and nicotine. Subsequently, senolytics, Dasatinib (D, 250nM) and Quercetin (Q, 375nM), were added or not for an additional 24 hours. After the 72-hour treatment, explants were collected and either fixed for immunofluorescence staining (IF) analyses or used for RNA extraction and quantitative reverse transcription PCR (qRT-PCR). Additionally, the supernatants were used to evaluate the expression of the senescence-associated secretory phenotype (SASP), conducted by Eve Technologies Corporation-Canada. This study used Luminex xMAP technology for multiplexed quantification of 96 Human cytokines, chemokines, and growth factors. Our results demonstrated that co-exposure to CBD, THC, and nicotine increases the expression of the senescence markers CDKN1A (0.1163±0.02384, p=0.0094, n=8) and CDKN2A (0.005793±0.002157, p=0.0516, n=8) encoding P21 and P16 respectively. Moreover, the IF staining showed increased expression of the DNA damage marker γH2A.X following treatment with CBD+THC+nicotine (7.375±2.154% vs 2.245±0.8329%, p=0.0604, n=6). Furthermore, the lung explants treated with cannabinoids and nicotine released cytokines and chemokines involved in immune responses and inflammation among others IL-6, IL-8, M-CSF, MCP-3, MIP-1β, TNFα, MIP-3β, and TSLP (p<0.05). The addition of D+Q reduced SASP secretion and showed a decreasing trend in expression of the senescence genes CDKN1A and CDKN2A compared to the triple treatment. Taken together, our results showed that the combinatorial exposure to CBD, THC, and nicotine increases senescence, DNA damage, and the senescence-associated secretory phenotypes (SASP) secretion. The use of senolytics (D+Q) may prove to be a promising therapeutic option, alleviating several of the negative effects induced by the different substances. RO1HL171915-01A1 RO!HL155104 RO1HL158532-03 ROIHL160570 This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.